Abstract
Development of a vaccine with enhanced efficacy compared to that of the Bacillus Calmette Guerin (BCG) vaccine is essential to reduce the global TB burden. This is challenging since an effective vaccine will need to induce protection that surpasses that induced by natural infection with M. tuberculosis and currently there are no identified biomarkers of protection. Nonetheless progress has been made over the last 20 years in the development and clinical evaluation of novel TB vaccines, evidenced by 15 candidate vaccines being tested in phase I clinical trials and 4 reaching phase IIb and III trials. In order to make further progress there is a need to further understanding of the interactions between M. tuberculosis and its host and for the development of ongoing partnerships to facilitate the design, harmonisation and funding of clinical trials.
Keywords: BCG, biomarker, correlates of protection, TB vaccine.
Current Respiratory Medicine Reviews
Title:Advances in TB Vaccinology
Volume: 9 Issue: 3
Author(s): Uta G. Hill and Clare R. Sander
Affiliation:
Keywords: BCG, biomarker, correlates of protection, TB vaccine.
Abstract: Development of a vaccine with enhanced efficacy compared to that of the Bacillus Calmette Guerin (BCG) vaccine is essential to reduce the global TB burden. This is challenging since an effective vaccine will need to induce protection that surpasses that induced by natural infection with M. tuberculosis and currently there are no identified biomarkers of protection. Nonetheless progress has been made over the last 20 years in the development and clinical evaluation of novel TB vaccines, evidenced by 15 candidate vaccines being tested in phase I clinical trials and 4 reaching phase IIb and III trials. In order to make further progress there is a need to further understanding of the interactions between M. tuberculosis and its host and for the development of ongoing partnerships to facilitate the design, harmonisation and funding of clinical trials.
Export Options
About this article
Cite this article as:
Hill G. Uta and Sander R. Clare, Advances in TB Vaccinology, Current Respiratory Medicine Reviews 2013; 9 (3) . https://dx.doi.org/10.2174/1573398X113099990021
DOI https://dx.doi.org/10.2174/1573398X113099990021 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Novel Diazenyl Containing Phenyl Styryl Ketone Derivatives As Antimicrobial Agents
Anti-Infective Agents Cytochrome <i>bc1-aa3</i> Oxidase Supercomplex As Emerging and Potential Drug Target Against Tuberculosis
Current Molecular Pharmacology Recognition and Function of HumanγδT Cells: Application for Tumor Immunotherapy
Current Immunology Reviews (Discontinued) Chlorella vulgaris Induces Apoptosis of Human Non-Small Cell Lung Carcinoma (NSCLC) Cells
Medicinal Chemistry Investigating Human P450s Involved in Drug Metabolism via Homology with High-Resolution P450 Crystal Structures of the CYP2C Subfamily
Current Drug Metabolism Microbial Efflux Pump -Specific Determinant to Fight Against the Antimicrobial Resistance in Pathogenic Strains
Current Chemical Biology Molecular Docking and Dynamics Simulation of Vibrio anguillarum Aspartate Semialdehyde Dehydrogenase with Natural Product Caulerpin
Letters in Drug Design & Discovery An In Silico Approach for Identification of Potential Anti-Mycobacterial Targets of Vasicine and Related Chemical Compounds
Combinatorial Chemistry & High Throughput Screening Editorial
Current Molecular Medicine Mutagenicity of N-oxide Containing Heterocycles and Related Compounds: Experimental and Theoretical Studies
Current Topics in Medicinal Chemistry Persistent Clinical Response of Infliximab Therapy in Patients with Refractory Rheumatoid Arthritis, over a 3-Year Period
Current Clinical Pharmacology The Current Chemical Utility of Marine and Terrestrial Filamentous Fungi in Side-Chain Chemistry
Current Organic Chemistry New Chemotherapeutic Strategies Against Malaria, Leishmaniasis and Trypanosomiases
Current Medicinal Chemistry Microbial Drug Efflux Proteins of the Major Facilitator Superfamily
Current Drug Targets Uncovering Drug Mechanism of Action by Proteome Wide- Identification of Drug-Binding Proteins
Medicinal Chemistry Molecular Targets for Design of Novel Inhibitors to Circumvent Aminoglycoside Resistance
Current Drug Targets Targeted Drug Delivery Using Tuftsin-bearing Liposomes: Implications in the Treatment of Infectious Diseases and Tumors
Current Drug Targets In Silico Methods for Predicting Ligand Binding Determinants of Cytochromes P450
Current Topics in Medicinal Chemistry 3D Cell and Scaffold Patterning Strategies in Tissue Engineering
Recent Patents on Biomedical Engineering (Discontinued) Lipid-based Self-Adjuvanting Vaccines
Current Drug Delivery